Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Ergomed PLC - Guildford, England-based company providing specialised services to the pharmaceutical industry - Reports a ‘good start’ to the year, with solid overall growth in revenue. Expects results for the full-year to be in-line with market expectations. Notes it has continued to invest in its commercial expansion, infrastructure, and platform. Says the investment has been primarily in its North American commercial capabilities, its senior leadership presence and in technology. Says it is ‘actively’ seeking and assessing potential acquistions. Remains in ‘robust’ financial position, debt free and with a strong balance sheet.
Current stock price: 979.00 pence, closing 7.6% higher in London on Thursday
12-month change: up 2.7%
Copyright 2023 Alliance News Ltd. All Rights Reserved.